CatalystWireBeta

Coiled Therapeutics plc (COIL): Placing of 27% of the market value

This situation live

COIL Coiled Therapeutics plc

£30m · 6.9p · −8% since the first step
Dilutive fundraise
Placing of 27% of the market value
completed
RaisePlacing · £8.5 million
Of market value26.6%
Reaction on the day+0%

As of 28 Sep 2026 ↗

Since Oct 2023: 301 situations of this kind – completed 77%, went quiet 23%; median share price -17% six months after they opened

Every step · 1
  1. 28 Sep 2026 completed – 80% of evaluable patients receiving twice-daily dosing achieved tumour stabilisation or regression sustained for six months or more, compared with a... ↗

What is happening

Coiled Therapeutics plc: Placing of 27% of the market value – completed. ['completed']

In short
Coiled Therapeutics plc is raising £8.5 million by placing, 26.6% of its market value; the shares moved +0% on the day.
Announced
28 Sep 2026 · completed · +0% on the day
Briefing Pro

New to Coiled Therapeutics plc? Get up to speed in 2 minutes.

What it does, how it got here, what management promised and delivered – written from its own announcements.

Get the COIL briefing →
Ask COIL Beta
Ask anything about Coiled Therapeutics plc

Answered from its own announcements and reported figures, every statement linked to its source.

From the company's own announcements. Not investment advice.

Also at Coiled Therapeutics plc 2 open
Insider conviction1 director buying – £39k in 1 buy Project milestonesAO-252 Phase I trial progress – Reformulation under way; efficacy data pushed to 2027 Dilutive fundraisePlacing of 27% of the market value – completed · closed Large acquisition / reverse takeoverAO-252 licence to Roquefort – AIM Readmission completed · closed Dilutive fundraisePlacing of 46% of the market value – announced · closed Coiled Therapeutics plc – company page →

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note